ANXIETY IN CHRONIC LIVER DISEASE: CHANGES POST TRANSPLANTATION
โ Scribed by MOORE, KATHLEEN A. ;BURROWS, GRAHAM D. ;HARDY, KENNETH J.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 140 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0748-8386
No coin nor oath required. For personal study only.
โฆ Synopsis
Anxiety is a common experience in chronic illness but for many with end-stage liver disease it is also associated with the stress of waiting for a donor organ to become available. Quality of life, work, family and social roles are all impaired and these losses may also contribute to depression. This article investigated anxiety and depression associated with end-stage liver disease and changes in these mood states following successful liver transplantation. Patients with non-alcoholic cirrhosis and healthy volunteers comprised the control groups. Signiยฎcant reductions in the measurement of anxiety and positive mood changes occurred as early as 1 month post transplant and were maintained across the course of the study. However, qualitative data suggest that discrete episodes of anxiety may still exist post transplant. These episodes appear to be related to maintaining the newly acquired `wellness' and availability of support. Most patients were able to resume work by 9 months post transplant.
๐ SIMILAR VOLUMES
Doppler waveform changes can be found in chronic parenchymal liver disease, especially in the late stages. We investigated the contribution of Doppler ultrasound in diagnosing early-stage chronic parenchymal liver disease. In this prospective study, 30 patients who had been diagnosed with chronic li
Infection with putative non-A to E hepatitis virus, designated GB virus C (GBV-C), was surveyed in 286 patients with chronic liver disease in Japan. RNA of GBV-C was detected, by reverse-transcription polymerase chain reaction with nested primers from the 5'-noncoding region, in 19 patients (6.6%) a
The tumorigenic potential of six post-transplant B-cell lymphoproliferative disease (PTLD) lesions was evaluated in SCID mice. Three animals developed local subcutaneous B cell tumours, two of which contained Epstein-Barr virus (EBV) DNA. Two animals developed CD3 positive thymic neoplasms, and one